IP Verse

Bispecific Antibodies Against Cd3epsilon And Bcma For Use In Treatment Of Diseases - EP3227333

PATENT ANALYSIS

Patent Details

Grant Date
Aug 16, 2023
Company
BRISTOL-MYERS SQUIBB COMPANY
Oppositions

J A KEMP LLP

PFIZER INC.

SCORPIO IP LIMITED

More patents of Bristol-Myers Squibb Company

EP3631454

EP3559230

EP3227333

Want to monitor this patent?

Feel free to send us a message here and we will get back to you